Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 135

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 135
---
 June 30, 2024 and 2023 and the years ended
December 31, 2023 and 2022:

|                                                                |     | Six Months Ended June 30,  
 2024                       |        |   |     | 2023 |        |   |     | Year Ended December 31, 
 2023                    |        |   |     | 2022 |        |   |
|:---------------------------------------------------------------|:----|:---------------------------|-------:|:--|:----|:-----|-------:|:--|:----|:------------------------|-------:|:--|:----|:-----|-------:|:--|
|                                                                |     | -£ in thousands; unaudited |        |   |     |      |        |   |     | -£ in thousands         |        |   |     |      |        |   |
| Cash used in operating activities                              |     |                            | (4,807 | ) |     |      | (3,881 | ) |     |                         | (6,826 | ) |     |      | (7,048 | ) |
| Cash generated from/(used in) provided by investing activities |     |                            |   (754 | ) |     |      |     20 |   |     |                         |   (265 | ) |     |      |   (220 | ) |
| Cash generated from/(used in) provided by financing activities |     |                            |  4,645 |   |     |      |  6,252 |   |     |                         | 10,226 |   |     |      |     47 |   |
| Net (decrease) increase in cash and equivalents                |     |                            |   (916 | ) |     |      |  2,391 |   |     |                         |  3,135 |   |     |      | (7,221 | ) |

Operating Activities

The following table presents
a summary of the cash used in operations as of the six months ended June 30, 2024 and 2023 and years ended December 31, 2023 and 2022:

|                                                                        |     | Six Months Ended June 30,  
 2024                       |        |   |     | 2023 |        |   |     | Year Ended      
 December 31,    
 2023            |        |   |     |